Intraoperative Imaging of Breast Cancer With Indocyanine Green
| Status: | Completed |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/7/2018 |
| Start Date: | July 2011 |
| End Date: | November 9, 2016 |
A Phase 0/1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subject Undergoing Breast Cancer Surgery
According to the World Health Organization, breast cancer is the most common cancer in women,
and is responsible for 686,000 new cases every year. The WHO also posit that nearly 420,000
women perished from the disease in 2002. Surgery remains the best option for patients
presenting with operable Stage I, II or III cancers. Breast conservation surgery has been
shown to be as efficacious as mastectomy. About 60-70% of these women with operable breast
cancer are breast conservation candidates. However, the need to achieve negative tumor
margins often requires a second operation (re-excision) in up to 70% of the women having
lumpectomy surgery. Currently, tumor margins assessment in the operating room is often
assessed grossly by palpation. The ability to evaluate tumor margin using our proposed
intraoperative imaging technique may provide the surgeon with an alternative, and hopefully,
more sensitive method to assess tumor margins which may decrease re-excision and the
morbidity associated with additional surgery, and, perhaps, lower the risk of local regional
recurrence.
and is responsible for 686,000 new cases every year. The WHO also posit that nearly 420,000
women perished from the disease in 2002. Surgery remains the best option for patients
presenting with operable Stage I, II or III cancers. Breast conservation surgery has been
shown to be as efficacious as mastectomy. About 60-70% of these women with operable breast
cancer are breast conservation candidates. However, the need to achieve negative tumor
margins often requires a second operation (re-excision) in up to 70% of the women having
lumpectomy surgery. Currently, tumor margins assessment in the operating room is often
assessed grossly by palpation. The ability to evaluate tumor margin using our proposed
intraoperative imaging technique may provide the surgeon with an alternative, and hopefully,
more sensitive method to assess tumor margins which may decrease re-excision and the
morbidity associated with additional surgery, and, perhaps, lower the risk of local regional
recurrence.
Inclusion Criteria:
1. Adult patients over 18 years of age
2. Women with newly diagnosed, operable invasive ductal carcinoma, invasive lobular
carcinoma or ductal carcinoma who are deemed breast conservation surgery candidates
(i.e. lumpectomy +/- sentinel node biopsy).
3. Breast cancer needs to be unifocal as determined by clinical parameters, e.g. by
palpation or by breast imaging findings including mammogram, US and/or breast MRI.
Multifocal disease, i.e. cancer confined to one quadrant, is eligible if patients are
deemed breast conservation candidates.
4. Subject capable of giving informed consent and participating in the process of
consent.
Exclusion Criteria:
1. Newly diagnosed breast cancer patients who are not breast conservation candidates and
those with multicentric breast cancer (breast cancer documented in multiple quadrants
by breast imaging or exam)
2. Pregnant women as determined by urinary or serum beta human chorionic gonadotropin
(hCG) within 72 hours of surgery
3. Subjects with a history of iodide allergies
4. At-risk patient populations
1. Homeless patients
2. Patients with drug or alcohol dependence
3. Patients unable to participate in the consent process
We found this trial at
1
site
3400 Spruce St
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-4000
Principal Investigator: Sunil Singhal, M.D.
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
Click here to add this to my saved trials
